| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/29/2005 | US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/29/2005 | US6872733 Benzimidazolone compounds |
| 03/29/2005 | US6872731 Imidazo-pyridine derivatives as ligands for GABA receptors |
| 03/29/2005 | US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione |
| 03/29/2005 | US6872705 Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions |
| 03/29/2005 | CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/29/2005 | CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/24/2005 | WO2005026172A1 Prostamide receptor antagonists |
| 03/24/2005 | WO2005026132A1 cAMP-SPECIFIC PHOSPHODIESTERASE INHIBITOR |
| 03/24/2005 | WO2005026128A1 Ophthalmic compositions for treating ocular hypertension |
| 03/24/2005 | WO2005026109A1 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy compounds as therapeutic agents |
| 03/24/2005 | WO2005025600A1 Drug inhibiting mobilization of adhesive cells into peripheral blood |
| 03/24/2005 | WO2005025598A1 Antibacterial drug for propionibacterium acnes |
| 03/24/2005 | WO2005025560A1 Ophthalmic composition |
| 03/24/2005 | WO2004096269A3 Botulinum neurotoxin for treating tics and obsessive compulsive behaviors |
| 03/24/2005 | WO2004096231A3 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns |
| 03/24/2005 | WO2004091438A3 Improved ophthalmic and contact lens solutions containing peptides as representative enhancers |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065211 Ester derivatives |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065137 Triamcinolone acetonide and anecortave acetate formulations for injection |
| 03/24/2005 | US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents |
| 03/24/2005 | US20050064539 Glycoprotein and process for producing the same |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050063997 Mixture of macrolactone antibodies and mycophenolic acid ; antiinflammatory agents; antiproliferative agents; topical drug |
| 03/24/2005 | US20050063996 Ocular solutions |
| 03/24/2005 | US20050063965 Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes |
| 03/24/2005 | US20050063961 Hematopoietic stem cells and endothelial progenitor cells; express the cell surface antigen CD31; delivering transgenes to the eye for cell-based gene therapy; treating ocular diseases such as retinopathy |
| 03/24/2005 | CA2538429A1 Antibacterial drug for propionibacterium acnes |
| 03/24/2005 | CA2537794A1 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy compounds as therapeutic agents |
| 03/23/2005 | EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 03/23/2005 | EP1516621A2 Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases |
| 03/23/2005 | EP1516620A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 03/23/2005 | EP1516542A1 Nutritional supplement to treat macular degeneration |
| 03/23/2005 | EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/23/2005 | EP1515974A2 Novel maxi-k channel blockers, methods of use and process for making the same |
| 03/23/2005 | EP1515955A2 Chemical process |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515731A1 Anti-spasmodic comprising xenon |
| 03/23/2005 | EP1515730A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 03/23/2005 | EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 03/23/2005 | EP1515722A2 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515721A1 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515716A2 Indole derivatives having anti-angiogenetic activity |
| 03/23/2005 | EP1515710A1 Method of treating rosacea by topical application of a cyclohexane derivative |
| 03/23/2005 | EP1280528B1 R-eliprodil for treating glaucoma |
| 03/23/2005 | CN1599748A Novel peptides and medicinal uses thereof |
| 03/23/2005 | CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 03/23/2005 | CN1599740A Amide substituted imidazopyridines |
| 03/23/2005 | CN1599739A Sulfonamido substituted imidazopyridines |
| 03/23/2005 | CN1599738A Urea substituted imidazopyridines |
| 03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
| 03/23/2005 | CN1599721A CCR-3 receptor antagonists VII |
| 03/23/2005 | CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 03/23/2005 | CN1599608A Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |
| 03/23/2005 | CN1597667A Quinazoline derivatives as angiogenesis inhibitors |
| 03/23/2005 | CN1597656A Eugenol ibuprofen ester medical compound and its preparation and preparation method |
| 03/23/2005 | CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 03/23/2005 | CN1596914A Medicine for treating eye disease caused by visceral disease |
| 03/23/2005 | CN1596890A Medicine having antivirus action |
| 03/23/2005 | CN1193996C Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193768C Artificial tear |
| 03/23/2005 | CN1193761C Controllable release system of glucocorticoid and its preparation method |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869950 Such as 1-(2-chloro-4-(n-octyloxy)benzyl)-2-methyl-6-(1-pentane -sulfonylcarbamoyl)benzimidazole |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869942 Comprises formoterol and corticosteroid; for use in treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease |
| 03/22/2005 | US6869935 Gene Therapy for proliferative vitreoretinopathy |
| 03/22/2005 | US6869789 Heparinase III and uses thereof |
| 03/22/2005 | CA2330092C Benzimidazole compounds as orl1-receptor agonists |
| 03/22/2005 | CA2257772C Bicyclic¬3.1.0|hexanes and related compounds |
| 03/17/2005 | WO2005023283A1 Ophthalmic composition |
| 03/17/2005 | WO2005023267A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists |
| 03/17/2005 | WO2005023258A1 Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives |
| 03/17/2005 | WO2004103376A3 Skin treatments |
| 03/17/2005 | WO2004089988A3 Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation |
| 03/17/2005 | US20050059956 Devices for intraocular drug delivery |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059688 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059674 reducing granulation tissue in humans having otitis and an open tympanic membrane comprising topically applying an aqueous suspension composition containing a combination of ciprofloxacin and dexamethasone |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis |
| 03/17/2005 | US20050059604 A GPCR-like protein for treating glaucoma |
| 03/17/2005 | US20050059583 For treating dry eyes; conjunctivitis |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050058667 Adjuvants for use in vaccines |
| 03/17/2005 | CA2537252A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists |
| 03/17/2005 | CA2536874A1 Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives |
| 03/16/2005 | EP1514867A2 Substituted phenyl derivatives, their preparation and use |
| 03/16/2005 | EP1514556A1 Botulinum toxin pharmaceutical compositions |
| 03/16/2005 | EP1514548A2 Use of cloprostenol fluprostenol, and their analogues to treat glaucoma and ocular hypertension |
| 03/16/2005 | EP1513880A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |